Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurobehavioral Mechanisms of Choice in Opioid Use Disorder
NCT03958474Phase 1Completed
- Start
- Aug 2019
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxycodone in opioid use disorder (OUD) (2 arms). Primary endpoint: Probabilistic Money vs Money Choice Task Performance at 16 days. Started Aug 2019; status: completed.
02
Drugs
oxycodone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03958474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03958474.